United States Biotechnology & Medical Research

Odyssey Therapeutics Inc (ODTX)

Track

Odyssey Therapeutics Inc experienced significant insider activity on May 8 and May 11, 2026. Multiple entities and individuals executed substantial purchases, alongside minor divestments by SR One Capital Management. These transactions occurred over three months ago, reflecting historical capital movements rather than current market conditions.
Ticker: ODTX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Odyssey Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
TPG GP A, LLC
Transaction date
Purchase
Price
135.61
Quantity 13,187 +46.5%
Value US$4,334,748
Li Nan (LN) Non-Executive Director
Transaction date
Purchase
Price
18.00
Quantity 1,111,111 +50.0%
Value US$19,999,998
Chu Shelley Non-Executive Director
Transaction date
Purchase
Price
18.00
Quantity 11,111 +inf%
Value US$199,998
LEIDEN JEFFREY M Non-Executive Director
Transaction date
Purchase
Price
20.00
Quantity 5,000 +1.9%
Value US$100,000
1.1
Haas Jason Chief Financial Officer Officer
Transaction date
Purchase
Price
20.00
Quantity 1,000 +1.6%
Value US$20,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-11 B Purchase
3.2
TPG GP A, LLC
13,187 +46.5%
135.61
US$4,334,748 		13,187 +46.5% 135.61 US$4,334,748
2026-05-11 2026-05-11 B Purchase
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
58,821 +24.8%
135.54
US$2,001,057 		58,821 +24.8% 135.54 US$2,001,057
2026-05-11 2026-05-11 S Sale
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
21,897 -29.0%
93.36
US$450,691 		21,897 -29.0% 93.36 US$450,691
2026-05-11 2026-05-11 B Purchase
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
133,333 +30.2%
18.00
US$2,399,994 		133,333 +30.2% 18.00 US$2,399,994
2026-05-11 2026-05-11 S Sale
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
277 -0.1%
18.00
US$4,986 		277 -0.1% 18.00 US$4,986
2026-05-11 2026-05-11 B Purchase
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
222,222 +13.8%
18.00
US$3,999,996 		222,222 +13.8% 18.00 US$3,999,996
2026-05-11 2026-05-11 S Sale
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
1,065 -0.1%
18.00
US$19,170 		1,065 -0.1% 18.00 US$19,170
2026-05-11 2026-05-11 B Purchase
Li Nan (LN)
Non-Executive Director
1,111,111 +50.0%
18.00
US$19,999,998 		1,111,111 +50.0% 18.00 US$19,999,998
2026-05-11 2026-05-11 B Purchase
Chu Shelley
Non-Executive Director
11,111 +inf%
18.00
US$199,998 		11,111 +inf% 18.00 US$199,998
2026-05-12 2026-05-08 B Purchase
Dimension Capital II, L.P.
Non-Executive Director
1,111,111 +50.0%
18.00
US$19,999,998 		1,111,111 +50.0% 18.00 US$19,999,998
2026-05-11 2026-05-08 B Purchase
LEIDEN JEFFREY M
Non-Executive Director
5,000 +1.9%
20.00
US$100,000 		5,000 +1.9% 20.00 US$100,000
2026-05-11 2026-05-08 B Purchase
1.1
Haas Jason

Chief Financial Officer

Officer
1,000 +1.6%
20.00
US$20,000 		1,000 +1.6% 20.00 US$20,000
Explore more

More insider trading research around Odyssey Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America